N@N

EMAN, POWR, ABIO, DARA, MDF, ANIK Are Seasonally Ripe To Go Down In the Next Five Weeks

June 4, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of eMagin Corp (AMEX:EMAN), PowerSecure International Inc (NASDAQ:POWR), ARCA BIOPHARMA INC (NASDAQ:ABIO), DARA BIOSCIENCES INC (NASDAQ:DARA), METRO HEALTH NETWORKS INC (AMEX:MDF), ANIKA THERAPEUTICS INC (NASDAQ:ANIK) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  EMAN    eMagin Corp                      -10.94%          91.67% (11 of 12)    Wednesday, June 13th 2012
  POWR    PowerSecure International Inc    -7.11%           100.00% (12 of 12)   Thursday, June 7th 2012
  ABIO    ARCA BIOPHARMA INC               -8.12%           75.00% (9 of 12)     Thursday, June 7th 2012
  DARA    DARA BIOSCIENCES INC             -18.22%          91.67% (11 of 12)    Thursday, June 28th 2012
  MDF     METRO HEALTH NETWORKS INC        -12.11%          86.67% (13 of 15)    Thursday, June 21st 2012
  ANIK    ANIKA THERAPEUTICS INC           -8.51%           91.67% (11 of 12)    Tuesday, July 3rd 2012

eMagin Corp (AMEX:EMAN) - eMagin Corporation operates in the field of organic light emitting diode technology (OLED). It designs, develops, manufactures, and markets OLED on silicon microdisplays; virtual imaging products, which utilize OLED microdisplays; and related products. The companys products include super video graphics array (SVGA) + OLED microdisplays; SVGA-3D OLED microdisplays; Super eXtended Graphics Array; WF05 prism optic with mounting brackets or combined with OLED microdisplays to form an optic-display module; and Design Reference Kits, which include a microdisplay and associated electronics to help original equipment manufacturers (OEMs) evaluate microdisplay products, and to assist in building and testing new products incorporating the companys microdisplays. The company also provides near-eye virtual imaging modules that incorporate its OLED-on-silicon microdisplays with its lenses and electronic interfaces for integration into OEM products; and Z800 3DVisors, which enable portable computing in personal entertainment, electronic gaming, and military training and simulation applications. In addition, eMagin performs research in the OLED field primarily for government customers. It serves OEMs in the military, industrial, medical, and consumer market sectors. The company sells its products directly in North America, Asia, and Europe; and through distributors in China and Korea. It also sells its products through its e-commerce Website, 3dvisor.com. The company was founded in 1993 and is headquartered in Bellevue, Washington.

PowerSecure International Inc (NASDAQ:POWR) - Metretek Technologies Inc. provides energy technology products, services, and data management systems to industrial and commercial users, and suppliers of natural gas and electricity. It designs, engineers, sells, and manages distributed generation systems, as well as provides energy management, engineering, consulting, and various natural gas measurement services. The company also owns and operates oil field production water disposal wells at facilities in northeastern Colorado. The company, founded as Marcum Natural Gas Services Inc. in 1991, is based in Denver.

ARCA BIOPHARMA INC (NASDAQ:ABIO) - ARCA biopharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of genetically-targeted therapies for heart failure and other cardiovascular diseases in the United States. The companys lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator for the treatment of chronic heart failure and other indications. Its development pipeline includes rNAPc2, a long-acting recombinant protein anticoagulant with a mechanism of action involving inhibition of tissue factor; and NU172, a short-acting anticoagulant, under collaboration agreement with Archemix Corporation, used during medical or surgical procedures. ARCA biopharma has a collaboration agreement with Laboratory Corporation of America to develop the genetic test for Gencaro. The company is headquartered in Broomfield, Colorado.

DARA BIOSCIENCES INC (NASDAQ:DARA) - DARA BioSciences, Inc., a development-stage pharmaceutical company, acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. The company has two drug candidates in development with cleared investigational new drug applications from the U.S. Food and Drug Administration. Its drug development programs include KRN5500, which completed a Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients; and DB959 for the treatment of metabolic diseases, including type 2 diabetes. The company is headquartered in Raleigh, North Carolina.

METRO HEALTH NETWORKS INC (AMEX:MDF) - Metropolitan Health Networks, Inc., through its subsidiaries, operates provider service networks (PSN) in the United States. Its PSN provides and arranges healthcare services to Medicare Advantage beneficiaries who participate in a Medicare Advantage plan. The company offers Medicare, a national health insurance program that covers the cost of hospitalization, medical care, and related health services for the U.S. citizens aged 65 and older, qualifying disabled persons, and persons suffering from end-staged renal disease. As of December 31, 2009, the PSN provided healthcare benefits to approximately 35,500 medicare advantage beneficiaries. The company was founded in 1996 and is headquartered in West Palm Beach, Florida.

ANIKA THERAPEUTICS INC (NASDAQ:ANIK) - Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company offers ORTHOVISC, which is used for the treatment of osteoarthritis in knees and various joints; ORTHOVISC mini that is used for the treatment of osteoarthritis in small joints; and MONOVISC, a single injection product used for the treatment of osteoarthritis in various joints. It also provides wound care products that comprise Hyalograft 3D used for the regeneration of skin; and Hyalomatrix used for the treatment of burns and ulcers. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, and ShellGel, which are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides INCERT, a HA based product used for the prevention of post-surgical adhesions; Hyalobarrier and Hyalobarrier Endo, which are post operative adhesion barriers for abdominal indications; and HYVISC, an HA product used for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine osteoarthritis. Additionally, the company offers Merogel, a product used for the treatment of ear, nose, and throat disorders. It also provides products for facial wrinkles and scar remediation under the HYDRELLE and ELEVESS brand names. Anika Therapeutics, Inc. sells its products directly, as well as through a network of distributors primarily in the United States, Europe, and Turkey. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641